Biggest News Aggregation in the World
📰 Phra News

Page 32 - Phra News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phra. Real-time updates on events, politics, business and more.

Flagship-founded Axcella to test midstage NASH drug in patients with long COVID in phase 2a trial

Axcella Therapeutics will test its midstage NASH drug in patients with long COVID, or the presence of symptoms in the months following COVID-19 diagnosis. By year's end, the company will start testing the treatment in about 40 patients who tested positive at least 12 weeks prior and has agreement on the phase 2a trial design with the U.K.'s regulatory body.
United Kingdom United States Stephen Hoge Atea Pharmaceuticals Puretech Health University Of Oxford

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science